SAFETY AND EFFECTIVENESS OF PEMETREXED IN PATIENTS WITH NON-SMALL CELL LUNG CANCER IN JAPAN BASED ON POST-MARKETING SURVEILLANCE

被引：0
|
作者：
Okubo, Sumiko [1 ]
Kobayashi, Noriko [1 ]
Taketsuna, Masanori [1 ]
Enatsu, Sotaro [1 ]
Nishiuma, Shinichi [1 ]
机构：
[1] Eli Lilly Japan, Kobe, Hyogo, Japan
来源：
JOURNAL OF THORACIC ONCOLOGY | 2012年 / 7卷 / 11期
关键词：
Post-Marketing Surveillance; NSCLC; Pemetrexed;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2-011
引用
收藏
页码：S485 / S485
页数：1
相关论文
共 50 条
  • [41] Safety and effectiveness of natalizumab: The 2-year interim results of the post-marketing surveillance in Japan
    Yokoyama, K.
    Sato, R.
    Makioka, H.
    Iizuka, Y.
    Hase, M.
    Ling, Y.
    Torii, S.
    Saida, T.
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 381 : 1069 - 1070
  • [42] Pemetrexed for advanced non-small cell lung cancer patients with interstitial lung disease
    Kato M.
    Shukuya T.
    Takahashi F.
    Mori K.
    Suina K.
    Asao T.
    Kanemaru R.
    Honma Y.
    Muraki K.
    Sugano K.
    Shibayama R.
    Koyama R.
    Shimada N.
    Takahashi K.
    [J]. BMC Cancer, 14 (1)
  • [43] Real-world safety and effectiveness of nivolumab for recurrent or metastatic head and neck cancer in Japan: a post-marketing surveillance
    Tahara, Makoto
    Kiyota, Naomi
    Nibu, Ken-ichi
    Akamatsu, Ayumi
    Hoshino, Tomohiro
    Hayashi, Ryuichi
    [J]. INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2021, 26 (09) : 1619 - 1627
  • [44] Safety and Effectiveness of Letermovir in Allogenic Hematopoietic Stem Cell Transplantation Recipients: Interim Report of Post-marketing Surveillance in Japan
    Itaru Hiraishi
    Rie Ueno
    Asuka Watanabe
    Shinichiroh Maekawa
    [J]. Clinical Drug Investigation, 2021, 41 : 1075 - 1086
  • [45] Real-world safety and effectiveness of nivolumab for recurrent or metastatic head and neck cancer in Japan: a post-marketing surveillance
    Makoto Tahara
    Naomi Kiyota
    Ken-ichi Nibu
    Ayumi Akamatsu
    Tomohiro Hoshino
    Ryuichi Hayashi
    [J]. International Journal of Clinical Oncology, 2021, 26 : 1619 - 1627
  • [46] Safety and Effectiveness of Letermovir in Allogenic Hematopoietic Stem Cell Transplantation Recipients: Interim Report of Post-marketing Surveillance in Japan
    Hiraishi, Itaru
    Ueno, Rie
    Watanabe, Asuka
    Maekawa, Shinichiroh
    [J]. CLINICAL DRUG INVESTIGATION, 2021, 41 (12) : 1075 - 1086
  • [47] Pemetrexed for Heavily Pretreated Patients With Advanced Non-small Cell Lung Cancer
    Lee, Jih-Hsiang
    Yu, Chong-Jen
    Chen, Kuan-Yu
    Shih, Jin-Yuan
    Lin, Yu-Lin
    Yang, Chih-Hsin
    [J]. JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2010, 109 (05) : 338 - 344
  • [48] Real-world effectiveness and safety of ibrutinib in relapsed/refractory mantle cell lymphoma in Japan: post-marketing surveillance
    Maruyama, Dai
    Omi, Ai
    Nomura, Fumi
    Touma, Tokiko
    Noguchi, Yukiko
    Takebe, Kyoko
    Izutsu, Koji
    [J]. INTERNATIONAL JOURNAL OF HEMATOLOGY, 2024, 119 (02) : 146 - 155
  • [49] Real-world effectiveness and safety of ibrutinib in relapsed/refractory mantle cell lymphoma in Japan: post-marketing surveillance
    Dai Maruyama
    Ai Omi
    Fumi Nomura
    Tokiko Touma
    Yukiko Noguchi
    Kyoko Takebe
    Koji Izutsu
    [J]. International Journal of Hematology, 2024, 119 : 146 - 155
  • [50] Role of Pemetrexed and Platinums Combination in Patients with Non-Small Cell Lung Cancer
    Chen, Manyin
    Shao, Wenlong
    He, Jianxing
    Wang, Daoyuan
    [J]. CURRENT DRUG TARGETS, 2010, 11 (01) : 29 - 36
12345